Alexandra Twin has 15+ years of experience as an editor and writer, covering financial news for public and private companies. Thomas J. Brock is a CFA and CPA with more than 20 years of experience in ...

The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with neuropathic corneal pain, according to a press release from Okyo.

Learn the benefits and risks of options and how to start trading options Lucas Downey is the co-founder of MoneyFlows, and an Investopedia Academy instructor. Samantha (Sam) Silberstein, CFP®, CSLP®, ...